Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?

Antibodies represent a relatively mature detection means and serve as therapeutic drug carriers in the clinical diagnosis and treatment of cancer—among which monoclonal antibodies (mAbs) currently occupy a dominant position. However, the emergence and development of small-molecule monodomain antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaofeng, Sun, Ling, Hu, Chengwu, Zheng, Feijian, Lyu, Zhengbing, Shao, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532743/
https://www.ncbi.nlm.nih.gov/pubmed/37755109
http://dx.doi.org/10.3390/md21090496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532743/
https://www.ncbi.nlm.nih.gov/pubmed/37755109
http://dx.doi.org/10.3390/md21090496

Ejemplares similares